4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-20-057336
Director sold 10,000 shares at $50.18 ($501,830)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schenkein David P Director | 2020-11-04 | Sale | −10,000 | $50.18 | $501,830 | 65,000 | D |
| Open-market sales · 10,000 sh · avg $50.18 · $501,830 | |||||||
Loading xslF345X03/doc4.xml…